General discussion, page-10093

Good point, and point taken.
I do think however that we know with a high degree of certainty that IHL has been working hard at the specifics for the past 9 months at least (the pregnancy metaphor continues). We've been made privy to some of those specifics, including the hiring and incentivizing of advisors, NASDAQ filings, etc. But more importantly, we know the track record and professionalism of the board of directors, and we understand that the NASDAQ listing is CENTRAL in their long term strategy for the company. We should assume there is an extremely powerful motivation to get this right, since trial funding hinges so directly upon it, as does the ability for the company and its programs to receive the level of attention they can only receive in the USA. Things are moving faster there for cannabinoids and psychedelics, both legally and entrepreneurially, and Incannex knows it is a worthy contender for the nexus of this chapter in the human saga.

So maybe consider that my analogy applies because investors have done all they can to ascertain the journey is going to happen: we've done our due diligence and sought to understand the company to the best of our abilities. That does not mean we run the airport the plane will fly from, nor will we be piloting the plane: we don't know the first thing about dozens of entities working together to make such a journey possible. The traveler is not in the driver seat by any stretch of the imagination, but if they planned their trip well, they can hold a high degree of confidence that the trip will indeed happen.

All the best.